• Filamin A interacts directly with the third intracellular loop and the C-terminal tail of CXCR4. 
Introduction
The warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome is a rare congenital immunodeficiency characterized by severe neutropenia, B-cell lymphopenia, delayed antibody class switching to immunoglobulin G, hypogammaglobulinemia, recurrent bacterial infections, and warts that develop after early exposure to human papillomavirus. In most cases, WHIM syndrome is associated with the dominant inheritance of variants of the chemokine receptor CXCR4 with mutations in the last 10 to 19 C-terminal amino acids. [1] [2] [3] [4] These mutations lead to a hyperfunctional receptor with impaired internalization and increased responsiveness to CXCL12. 2, 5 Dysfunctional CXCR4-mediated signaling is a common manifestation in WHIM patients, even in cases in which the disorder is not genetically associated with CXCR4 mutations. 6 The causal role of CXCR4 in WHIM syndrome was confirmed in several cell and animal models, 7, 8 including a knockin mouse bearing the common WHIM syndromecausing mutation CXCR4 R334X in heterozygotes. 9 Treatment with a CXCR4 antagonist transiently reverses most associated immunologic anomalies in WHIM patients.
immunoglobulin-like b-sheet tandem repeats separated into 2 rods by 2 hinge regions. 23 Repeat 24 mediates protein dimerization and endows the dimer with a structure that assists orthogonal branching of actin filaments. FLNA activity nonetheless extends beyond its F-actin crosslinking ability because it acts as a scaffold for the binding of more than 90 partners, 23 most of which interact with the second rod (repeats 16 to 23). The chemokine receptors CXCR4 and CCR2b are among the FLNA binding partners. FLNA interaction with CXCR4 triggers and stabilizes receptor clustering at the cell surface during HIV-1 infection 22 ; its binding to CCR2b is necessary for efficient receptor endocytosis and intracellular trafficking of endocytic vesicles. 24, 25 Indeed, FLNA has dual effects on the endocytosis of other receptors; it stabilizes rectifying K 1 channels, 26 calcitonin, 27 or cystic fibrosis transmembrane conductance regulator 28 receptors at the plasma membrane but sustains dopamine D3 receptor endocytosis. 29 Whether FLNA interacts with WHIM mutants and the influence of this putative interaction on b-arr binding and receptor endocytosis are not known but are potentially important in the dysfunction of WHIMassociated CXCR4 mutants.
Here we show that, in addition to its interaction with the C-tail, FLNA bound the 
Methods
Human embryonic kidney (HEK) -293 and HEK-293T cells were obtained from the American Type Culture Collection. The M2 (FLNA-deficient) and the isogenic A7 (FLNA-expressing) melanoma cell lines were maintained in minimal essential medium (Invitrogen) supplemented with 5% fetal calf serum; A7 cells also received 0.5 mg/mL G418 (Sigma-Aldrich). X4
WT and X4 WHIM complementary DNA cloned in the m5p retroviral system were kindly provided by M. Kallikourdis and A. Viola. 30 ICL3 mutations were generated with the Quickchange Site-Directed Mutagenesis Kit (Stratagene) by using specific primers (see supplemental Methods available at the Blood Web site for more detail). These X4 constructs as well as the pnglv-gag-pol and envVSVG plasmids were transfected in HEK-293T cells by using jetPEI (Polyplus Transfection) to generate retroviral particles used to transduce the cell lines, as described. 31 ,32 X4 KG2A and X4 S324X mutants were generated by site-directed mutagenesis using specific primers. The X4 S324X mutant was further engineered to generate ICL3 mutations as above.
For pull-down assays, recombinant FLNA constructs were expressed and purified as described, 33 and biotinylated ICL3 peptides were synthesized at the Centro Nacional de Biotecnología Core Facility. Glutathione S-transferase-barr2 was obtained by restriction-free cloning 34 using pGEX 4T1 (GE Healthcare) and rat b-arr2-enhanced green fluorescent protein as templates and Phusion DNA polymerase (Thermo Scientific). Immunoblotting was performed by using anti-FLNA monoclonal antibody1-7 35 or horseradish peroxidase-conjugated anti-His monoclonal antibody (Sigma-Aldrich). Surface plasmon resonance (SPR) experiments were performed by using Biacore 3000 (GE Healthcare), and sensograms were analyzed with BIAevaluation Software 4.1. Data sets were processed by a double-referencing method. For immunoprecipitation, we used specific antibodies and HEK-293 or green fluorescent protein (GFP) -b-arr2-HEK-293 cells that expressed the indicated receptors (supplemental Methods).
CXCL12-induced receptor endocytosis was analyzed by fluorescenceactivated cell sorter (FACS) (Cytomics FC500; Beckman Coulter). Receptor endocytosis was calculated as the quotient of the geometric mean fluorescence intensity of treated cells and the mean fluorescence intensity of unstimulated cells expressed as a percentage; 100% corresponds to receptor expression on the surface of unstimulated cells.
HEK-293T cells were transiently transfected with X4 WHIM and X4 WHIMICL3DCt plasmids and were analyzed by fluorescence microscopy (Olympus Fluoview FV-1000 microscope fitted with a 603 NA1.4 objective) using anti-early endosome antigen 1 (EEA1) (BD Biosciences) or anti-lysosomalassociated membrane protein-1 (LAMP-1) antibodies (Abcam) for costaining. Images were processed with ImageJ software (National Institutes of Health). ERK activation, actin polymerization, and chemotaxis assays were performed as described. 36, 37 Results CXCR4 C-tail is not the only FLNA binding motif Studies have shown that the CXCR4 C-tail binds to the atypical FLNA repeat 10. 22, 38 Sequence analysis predicted a small motif at the CXCR4 C-tail, with charge and secondary structure similar to those identified in CD4 as important for binding to FLNA repeat 10 (supplemental Figure 1A) . This motif coincides in CXCR4 and CD4 with a phorbol ester-activated endocytosis signal and bears an AP-2 clathrin adaptor-reactive sequence. 15 In CD4, residues E 416 and K 417 , located in a helix turn (1Q68 structure), are critical for FLNA binding. We thus generated a CXCR4 mutant in which the homologous residues K 331 and G 332 were replaced with alanine (X4 KG2A ); a mutant lacking the entire motif (X4 S324X ) was also engineered. Cell surface expression of X4 KG2A and X4 S324X mutants was comparable to that of the X4
WT receptor (not shown), although CXCL12-induced internalization was reduced (supplemental Figure 1B) . As predicted, the X4 S324X deletion mutant was completely resistant to CXCL12-induced internalization because it lost most S/T residues involved in receptor endocytosis. 16 The X4 KG2A receptor internalization rate was reduced, and it was endocytosed only after lengthy incubation with CXCL12. This severe impairment in X4 KG2A internalization might be the result of mutation-dependent conformational changes in adjacent regions, particularly the a-helix, which bears the di-leucine (I 328 L 329 ) motif implicated in CXCR4 endocytosis. 15, 16 FLNA is important for transduction of some CXCR4-mediated signaling pathways, including CXCL12-induced F-actin polymerization. 22 Analysis of this process indicated that CXCL12-induced F-actin formation was clearly enhanced by both of our C-tail mutants compared with X4 WT (supplemental Figure 1C) , which paralleled the impaired endocytosis of mutant CXCR4 receptors with their enhanced signaling ability.
We used immunoprecipitation assays to test whether the X4 mutations affected interaction with FLNA. The X4
WT receptor as well as the X4 KG2A and X4 S324X mutants coprecipitated with endogenous FLNA (supplemental Figure 1D) For personal use only. on July 15, 2017. by guest www.bloodjournal.org From pointing toward the CD groove of an FLNA b-sheet repeat. 23, 39 By using the FLNA-binding motif, we searched for a potential FLNAbinding site on CXCR4 and found a sequence in the C-terminal part of the ICL3 ( Figure 1A ).
To test whether the predicted CXCR4 motif binds to FLNA, we performed pull-down experiments using synthetic peptides with (ICL3) or without (ICL3DCt) the LKTTVILIL motif ( Figure 1B ) as bait; an ICL3 peptide lacking the N-terminal residues (ICL3DNt) and another resembling the second intracellular loop (ICL2) were used as controls. Peptides were biotinylated at the N terminus to allow directed immobilization on streptavidin beads. ICL3 and ICL3DNt peptides readily precipitated FLNA from HEK-293 cell lysates, whereas ICL3DCt did not ( Figure 1C) .
We analyzed the role of the LKTTVILIL motif in FLNA interaction in living cells by deleting these residues in the ICL3 region of the X4 S324X receptor, which lacks the putative FLNA repeat 10 interaction motif at the C-tail. Whereas the X4 S324X receptor retained FLNA binding, deletion of the ICL3 C-terminal amino acids (residues 238 to 246; X4 S324X -ICL3DCt) disrupted interaction with the actin-binding protein ( Figure 1D -E). Deletion of the ICL3 N-terminal residues (amino acids 223 to 230; X4 S324X -ICL3DNt) had little or no effect on FLNA coprecipitation ( Figure 1D -E), coinciding with the pull-down assay data. The results suggest that the ICL3 C-terminal region constitutes an unreported CXCR4 motif for FLNA binding in vitro and in vivo. 
FLNA-ICL3 interaction is sensitive to p160ROCK inhibition
The p160 Rho kinase (ROCK1) participates in CXCR4 signaling, 40 and FLNA has been implicated in CXCR4-mediated activation of the RhoA-ROCK pathway. 22 Because FLNA interaction with some partners is dependent on actomyosin contraction, which confers mechanical force and exposes cryptic FLNA binding sites for its ligands, 41, 42 we tested whether the ROCK pathway, a wellcharacterized upstream activator of myosin II, affected CXCR4-FLNA binding. In cells expressing the X4
WT receptor, CXCL12 stimulation induced a transient increase in CXCR4-bound FLNA. This was prevented by cell pretreatment with the ROCK inhibitor Y27632 ( Figure 3A ), suggesting that F-actin stabilization and subsequent actomyosin contraction affected the FLNA-CXCR4 interaction. In contrast, CXCL12 stimulation did not enhance FLNA interaction with an X4 receptor mutant that lacked the ICL3 C-terminal region (X4-ICL3DCt) ( Figure 3A ). Results were similar when FLNA was immunoprecipitated; we found that CXCL12-induced Y27632-sensitive FLNA association with X4
WT was not observed in X4-ICL3DCt-expressing cells ( Figure 3B ). These findings suggest that ligand-induced conformational changes promote FLNA-CXCR4 interaction in an ROCK-and ICL3-dependent manner.
FLNA-ICL3 interaction regulates CXCL12-induced CXCR4 endocytosis
Because FLNA regulates CCR2b internalization, 24, 43 we tested whether the FLNA-ICL3 interaction affects CXCR4 endocytosis. In unstimulated cells, receptor expression at the cell surface was comparable ( Figure 4A ). CXCL12 stimulation triggered endocytosis of all receptors, but X4-ICL3DCt internalization was more rapid and persistent than that of X4 WT or X4-ICL3DNt ( Figure 4B ). Given that lack of FLNA-ICL3 binding appeared to accelerate receptor endocytosis, we tested whether this interaction also affected internalization of a WHIM-like CXCR4 receptor. By using CXCR4 R334X , a common WHIM syndrome-causing mutation that renders an endocytosis-resistant receptor, 2 we deleted the ICL3 Nor C-terminal region (X4 WHIM -ICL3DNt and X4 WHIM -ICL3DCt); these constructs were expressed in HEK-293 cells, and CXCL12-induced endocytosis was analyzed by FACS. X4
WHIM was not internalized after CXCL12 stimulation, which was also the case for X4 WHIM -ICL3DNt; in contrast, X4 WHIM -ICL3DCt was endocytosed shortly after CXCL12 stimulation ( Figure 4C ). Histograms for each construct before and after 60 minutes of stimulation are shown from a representative experiment in Figure 4D .
We analyzed CXCL12-induced receptor endocytosis by immunofluorescence in the presence of specific markers of the endocytic pathway. In accordance with its lack of internalization in FACS analyses, X4
WHIM receptor showed membrane-like staining; it did not colocalize with EEA1 (Figure 4Ea . 43 FLNA-ICL3 interaction appears to act as a major regulator of CXCL12-induced CXCR4 internalization, even for WHIM-like mutant receptors.
FLNA deficiency enhances CXCL12-induced endocytosis of WHIM-like CXCR4
To further study the role of FLNA in the endocytosis of WHIM-like receptors, we compared CXCR4 internalization in A7 (FLNAexpressing) and M2 (FLNA-deficient) cells. FLNA deficiency impaired basal cell surface levels of X4
WT and X4 WHIM receptors. Whereas stably transfected A7 and M2 cells showed comparable total levels of these receptors (as indicated by GFP tag fluorescence), FLNA deficiency reduced cell surface localization (as shown by anti-CXCR4 antibody staining) ( Figure 5A ). We observed similar FLNAdependent modulation of basal cell surface expression for X4 WHIM and X4
WHIM -ICL3DCt transiently transfected in A7 and M2 cells BLOOD Figure 5B ). In both cell types, cell surface levels of X4 WHIM -ICL3DCt tended to be lower than those of X4 WHIM , although values were not significant.
In addition to the role of FLNA in stabilizing CXCR4 at the plasma membrane in basal conditions, experiments with M2 and A7 cells confirmed FLNA participation in CXCL12-induced receptor endocytosis. The X4 WHIM mutant, which was insensitive to CXCL12-induced internalization in A7 cells, was endocytosed efficiently in M2 cells ( Figure 5C ). Moreover, as in HEK-293 cells, CXCL12 induced X4
WHIM -ICL3DCt internalization in FLNA-expressing and -deficient cells, although receptor endocytosis was more robust in cells that did not express FLNA ( Figure 5C ). These results confirm the importance of FLNA interaction with the ICL3 domain for CXCL12-induced internalization of WHIM-like CXCR4 mutants. Figure 6C ). Densitometric quantification of immunoblots indicated a receptor-independent ERK activation peak at the same time and of approximately the same degree; however, we observed a decrease in phospho-ERK levels only in cells expressing X4 WHIM -ICL3DCt receptors ( Figure 6D ). Likewise, we did not find the amplification of the CXCL12-induced chemotaxis that is characteristic of WHIM receptors in cells that overexpressed the X4 WHIM -ICL3DCt receptor ( Figure 6E ). These data indicate that FLNA-ICL3 interaction is necessary for the WHIM mutant receptor gain-of-function phenotype.
FLNA regulates b-arr2 interaction with ICL3
In addition to the FLNA-binding site described here, ICL3 bears a b-arr2 interaction motif. 20, 21 By using SPR, we found that recombinant b-arr2 interacted with biotinylated ICL3 and ICL3DCt peptides immobilized on streptavidin, but not with streptavidin alone (Figure 7A ), confirming the presence of a b-arr2-binding site in the ICL3 N-terminal region. Because of the proximity of FLNA and b-arr2-binding motifs, we tested whether both molecules can bind simultaneously to ICL3. The FLNA(16-23) fragment was injected onto immobilized ICL3 or ICL3DCt (FLNA-negative control) prior to b-arr2 injection. As anticipated, FLNA(16-23) did not affect b-arr2 interaction with ICL3DCt ( Figure 7B ), but it partially inhibited b-arr2 binding to ICL3 ( Figure 7C ); we were unable to saturate ICL3 at the FLNA(16-23) concentration used (400 nM), which might explain this partial inhibition.
b-arr2 injection onto immobilized ICL3 also interfered with FLNA (16-23) binding to the peptide ( Figure 7D ). In this case, FLNA (16) (17) (18) (19) (20) (21) (22) (23) showed more rapid association rates and slower dissociation rates to the b-arr2-ICL3 complex than to ICL3 alone ( Figure 7D) , suggesting that the FLNA fragment interacts with b-arr2 rather than with ICL3. Figure 7E ). SPR and pull-down assays thus suggest some competition between b-arr2 and FLNA for ICL3 binding in vitro.
We next analyzed whether b-arr2 and FLNA also compete in vivo. We expressed X4 WHIM , X4 WHIM -ICL3DNt, and X4 WHIMICL3DCt receptors in HEK-293 cells stably expressing b-arr2-GFP; b-arr2 was specifically precipitated. A significantly larger amount of b-arr2 coprecipitated with X4
WHIM compared with X4 WHIMICL3DNt or X4 WHIM -ICL3DCt receptors ( Figure 7F) ; there was a tendency toward more b-arr2 binding to X4 WHIM -ICL3DCt than to X4 WHIM -ICL3DNt, which is consistent with loss of the b-arr2 motif in the latter. 21 b-arr2 coprecipitation with FLNA was observed in all conditions, indicating that this interaction was direct and did not require prior b-arr2 binding to CXCR4. These results suggest that FLNA does not compete with but rather facilitates b-arr2 binding to ICL3 in vivo.
Discussion
Here we report identification of an FLNA-binding motif in the CXCR4 ICL3 as an important regulatory element in CXCL12-induced internalization not only of the WT receptor but also of the endocytosis-resistant CXCR4 R334X mutant, the most common WHIMassociated receptor. We base this conclusion on the observations that We previously showed that FLNA repeat 10 interacts with the CXCR4 C-tail, 22 and our results suggest that the ICL3 is also a binding motif for FLNA repeats 19 and 23. This ICL3 FLNA-binding motif contains hydrophobic amino acid that can fit the hydrophobic cleft BLOOD
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formed by CD strands of FLNA repeats ( Figure 1A) . 23, 39 The ICL3 binding motif includes 6 residues predicted to lie within the receptor transmembrane domain. 45, 46 To the best of our knowledge, there is no precedent in undisrupted cells for interaction between a cytoplasmic protein and one partially embedded in the membrane. Further structural analysis is necessary to determine precisely how FLNA gains access to this region.
Although these two binding sites are independent, they probably work in concert for CXCR4 interaction after CXCL12 stimulation. We hypothesize that the C-tail masks ICL3 in the resting state, but receptor activation removes this steric hindrance.
47 CXCL12 increased FLNA binding to complete CXCR4, but not to a truncated ICL3 mutant still able to bind FLNA through its C-tail domain ( Figure 3A) . The increase in FLNA binding to CXCR4 was ROCKdependent, and FLNA is involved in CXCL12-induced RhoA activation and myosin light chain phosphorylation. 22 We thus propose a model of sequential interaction between FLNA and CXCR4, in which constitutive FLNA repeat 10-CXCR4-C-tail binding initiates a CXCL12-induced signaling cascade that culminates in myosin contraction and enables binding of FLNA repeats 19 to 23 to ICL3. This model also explains the enhanced FLNA coprecipitation with C-tail-truncated CXCR4 compared with WT in resting conditions (supplemental Figure 1D) , because C-tail truncation would expose ICL3 for FLNA binding. Each individual CXCR4 domain nonetheless appears to be dispensable for FLNA binding, because FLNA coprecipitated with CXCR4 mutants that lack the C-tail but have an intact ICL3 ( Figure 1D) , as well as with ICL3-truncated mutants that maintain the C-tail (Figure 3A-B) .
How myosin contraction enhances FLNA-CXCR4 interaction is not entirely clear. F-actin rearrangements could induce conformational changes in both CXCR4 and FLNA. CXCL12 modifies CXCR4 conformation, leading to receptor dimerization and activation 48, 49 ; both processes require actin cytoskeleton dynamics. 50 Since the ICL3 FLNA-binding motif is predicted to lie partially within the lipid bilayer, CXCL12-induced actomyosin contraction might induce conformational changes that expose the ICL3 motif, permitting its interaction with FLNA repeats 19 to 23.
Myosin contraction might also promote FLNA-CXCR4 interaction by directly affecting the structure of FLNA repeats involved in ICL3 binding. Repeats 19 and 21 are in an autoinhibitory conformation because of the occupancy of their CD faces (used to bind to partners) with strand A of their preceding repeats. 23, 39 This autoinhibition must be removed for binding to partners. For example, myosin contraction enables FLNA repeat 21 to interact with the cytoplasmic tail of b-integrins by inducing local FLNA deformation. 41 We cannot rule out the possibility that a similar mechanism initiates ICL3-FLNA interaction after CXCL12 stimulation, at least for the WT receptor.
Our study identifies a role for FLNA in stabilizing CXCR4 at the cell surface. Abrogation of the FLNA-ICL3 interaction accelerated CXCR4 internalization ( Figure 4B ) and, more importantly, allowed CXCL12-induced endocytosis of a WHIM-like receptor ( Figure 4C ). The endocytosed X4
WHIM -ICL3DCt mutant colocalized with early endosome and lysosomal markers in a time-dependent manner. The role of FLNA in stabilizing CXCR4 at the cell surface is probably multifaceted. Part of the effect might be explained by FLNA-mediated regulation of the b-arr2-ICL3 interaction; indeed, b-arr2 binding to ICL3 stabilizes cell surface WHIM receptors. 21 Reduced expression of CXCR4 WT and WHIM mutants at the unstimulated M2 cell membrane nonetheless suggests that FLNA has additional functions in receptor stabilization at the cell surface. One of these functions, supported by our previous data, could be stabilization of the cortical actin cytoskeleton. The actin cytoskeleton has a dual effect on clathrinmediated endocytosis; whereas F-actin formation is necessary for endocytosis, 51 inhibition of actin turnover also prevents receptor internalization. 52 Precise control of F-actin remodeling appears to be central to endocytosis, and FLNA seems to be an important element in reinforcing the submembrane cortical cytoskeleton. 53 FLNA participates in this process by enabling cofilin phosphorylation and inactivation, 22 which stabilizes F-actin and promotes HIV-1-induced CD4 and CXCR4 clustering at the cell surface. FLNA could thus act as a mechanotransducer that regulates endocytosis of WHIMlike receptors by affecting rigidity of the cortical cytoskeleton.
Our data show that FLNA not only links CXCR4 to the actin cytoskeleton, but it also shapes receptor signaling through its interaction with ICL3; indeed, abrogation of FLNA-ICL3 interaction attenuated ERK signaling and chemotaxis. These effects on CXCR4 signaling might rely on FLNA-mediated regulation of the b-arr2-ICL3 interaction. Previous studies showed that b-arr2 binds separately to the CXCR4 C-tail and to the ICL3 N-terminal SHSK motif. 20, 21 b-arr2 binding to these two sites has distinct functional consequences; whereas b-arr2-C-tail interaction mediates receptor desensitization and endocytosis, its binding to ICL3 is important for b-arr2-mediated signaling. 20 b-arr2 interaction with the WHIM-like CXCR4 S338X mutant is preserved and the receptor is not internalized; instead, it enhances b-arr2-mediated ERK activation and chemotaxis, 21 two pathways critically dependent on b-arr2. 19, 20 Our in vitro data using SPR and pull-down assays suggest that b-arr2 and FLNA compete for binding to ICL3. The in vivo data nonetheless indicate that b-arr2 binding to X4 WHIM depends on FLNA-ICL3 binding because more b-arr2 coprecipitated with X4 WHIM than with X4 WHIM -ICL3DCt. Although b-arr2 levels are similar in FLNA-deficient M2 cells and the FLNA-expressing A7 subclone, CXCL12-induced ERK activation is lower in M2 than in A7 cells ( Figure 7A ), indicating the functional importance of FLNA-b-arr2 crosstalk. FLNA might present b-arr2 to ICL3, thus stabilizing the interaction among the three partners. b-arr2 did not coprecipitate with X4 WHIM -ICL3DNt, although this receptor conserves the FLNA-binding domain and FLNA-b-arr2 interaction, which supports a model in which FLNA and b-arr2 cooperate to bind ICL3 at high affinity. This docking is probably more critical in C-tail-truncated receptors, in which b-arr2-C-tail interaction is lost. Our model would explain the parallel enhancement of FLNA (this study) and b-arr2 binding 21 to C-tail-truncated CXCR4 mutants compared with WT receptors.
CXCR4 and FLNA have been linked independently to cancer metastasis. Our results suggest that FLNA might contribute to metastasis by direct regulation of CXCR4. FLNA-ICL3 interaction would reduce CXCR4 endocytosis and endow tumor cells with more sustained adhesive and migratory capacities, thus aiding metastasis. Whereas the CXCR4 contribution to the metastatic process is not debated, FLNA appears to have a dual role. 54 FLNA reduction could conceivably render tumor cells less invasive, more sensitive to mechanical stress, and less adhesive, which would affect metastasis initiation and colonization of distant organs. Some studies have results that coincide with this view; for instance, FLNA depletion reduces in vitro migration and invasion of melanoma cells 55 and reduces the For personal use only. on July 15, 2017. by guest www.bloodjournal.org From metastatic potential of breast cancer and hepatocarcinoma cells in mouse models. 56, 57 Reduced FLNA expression is also associated with decreased lymph node metastasis, neural invasion, and enhanced distant metastasis-free survival in breast cancer patients. 57, 58 In contrast, FLNA absence correlates with reduced lymph node metastasis and poor prognosis in nasopharyngeal cancer. 59 The role of FLNA in metastasis thus appears to be dependent on tumor type; whether CXCR4 expression is associated with this tumor specificity remains to be determined.
CXCR4 hyperactivation is proposed as a major underlying pathogenic mechanism in the WHIM syndrome. 60 A recent phase 1 trial showed the clinical effectiveness of the CXCR4 antagonist plerixafor (AMD3100) in partially restoring the immune functions of 3 patients. 61 On the basis of our results, it is tempting to hypothesize blockade of the FLNA-ICL3 interaction as a new therapeutic strategy for modulating surface expression and normalizing signaling of CXCR4 mutants in the WHIM syndrome.
